Jasper Therapeutics (JSPR) Misses Q3 EPS by 113c

Jasper Therapeutics (NASDAQ: JSPR) reported Q3 EPS of ($1.13).

For earnings history and earnings-related data on Jasper Therapeutics (JSPR) click here.

You May Also Be Interested In

• Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
• Bernstein on Oracle (ORCL): 'We believe that the company is nearing the end of their need for additional cash'
• Yatsen Holding (YSG) Reports Q2 Loss of $0.16